A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease.
about
High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson diseaseSignal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease.New developments of brain imaging for Parkinson's disease and related disorders.Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism.Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.Positron emission tomography and single-photon emission computed tomography in central nervous system drug development.Technology insight: imaging neurodegeneration in Parkinson's disease.Variability of EMG patterns: a potential neurophysiological marker of Parkinson's disease?Mild cognitive impairment in Parkinson's disease: the challenge and the promiseMagnetic resonance imaging for the diagnosis of Parkinson's disease.Biomarkers in Huntington's and Parkinson's Disease.Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations.Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome.Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease.Detection of Parkinson's disease by MRI: Spin-lattice distribution imaging.Reply: Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's diseaseNeuroimaging in Parkinson's disease
P2860
Q22065275-D5822FF8-C832-4122-9AF5-9F29548F02F1Q30583514-5B5FEFFD-3A75-4420-BDB5-FC1FE9ACFD0AQ30886687-416A4F6F-A5C3-412D-889E-6F8E39CB741AQ31050288-58D5AE63-AF20-468B-9058-B84382E5775DQ33514021-22EE1A60-14A9-4F4C-8211-04BC71366486Q34015541-1E7004A8-9E83-43C1-AA31-A3012360D4B8Q36129732-4B616341-FE89-4095-BAB8-C906E272F330Q37125936-B5467784-CB5C-4EDF-AA6F-23B5E3D9448BQ37186446-02BE0FEB-B5E7-4F13-A106-2803B3772F35Q37196144-1F85F5A0-8A51-4BE6-AEBE-B52A6A7FE13EQ39220904-1D1F186C-A0E2-4FBB-B3DC-B1F98F62A515Q45295847-39BB1A80-FCEE-4A4C-9F52-611735A3F434Q46891214-146653E3-BCEC-4FF6-807C-AD13DC42B180Q46931704-17E0249F-B51E-41B8-AC44-A010FFE29AB7Q48282777-165A09A4-5CAE-4A35-A904-E8376868A7A8Q48945445-969D50EC-5C51-4DD3-B755-F5DB5B03988FQ57088827-D9F67B2A-E6BC-45EA-B6EF-A50EEEC9E8E5Q57088961-C641A159-ACA4-4750-9DD2-CE748F0475D9
P2860
A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
A comparison of (18)F-dopa PET ...... gnosis of Parkinson's disease.
@en
type
label
A comparison of (18)F-dopa PET ...... gnosis of Parkinson's disease.
@en
prefLabel
A comparison of (18)F-dopa PET ...... gnosis of Parkinson's disease.
@en
P2093
P356
P1433
P1476
A comparison of (18)F-dopa PET ...... gnosis of Parkinson's disease.
@en
P2093
P304
P356
10.1212/WNL.56.9.1195
P407
P577
2001-05-01T00:00:00Z